Embryoglycans regulate FGF-2-mediated mesoderm induction in the rabbit embryo.
Several peptide growth factors, including members of the fibroblast growth factor (FGF) superfamily, are potential inducers of mesoderm in vertebrates. Receptor binding of basic FGF (FGF-2) is promoted by cell surface or extracellular matrix proteoglycans. The substantial biosynthesis of proteoglycans by embryonic cells (called embryoglycans) and their potential role as ligands for growth factor receptors led us to examine the role of embryoglycans that carry the developmentally regulated oligosaccharide epitope TEC 1, in the binding of FGF-2 to cultured rabbit inner cell masses (ICMs). Culture of isolated ICMs in the presence of FGF-2 gave rise to well delimited colonies with migrating cells at the periphery. In these cells, TEC 1 staining shifts from a punctate pattern over the entire membrane, to an apical, finely granular distribution with some internalization. This shift occurs after 96 hours in culture. Here we show that: (1) migrating cells are mesoderm-like in phenotype; (2) antibodies against TEC 1 blocked FGF-2 mediated differentiation in vitro; (3) antibodies against TEC 1 selectively blocked binding of FGF-2 to ectodermal receptors and, vice versa, the binding of TEC 1-specific antibodies to ectodermal cells can be competed by excess FGF-2; (4) the same switch in TEC 1 staining patterns was observed in vivo, between the day 7 and the day 9 rabbit embryo. These data suggest the involvement of defined species of embryonic cell surface epitopes in the regulation of FGF-2 receptor binding. Moreover, this proposed binding activity is temporally restricted to ectodermal cells and disappears early during differentiation. Thus, the apical TEC 1 redistribution can be considered as the earliest indicator of mesoderm formation.
Dvorák
P
P
Developmental Biology Unit, Institute of Animal Physiology and Genetics, Czech Republic.
Flechon
J E
JE
Thompson
E M
EM
Horák
V
V
Adenot
P
P
Renard
J P
JP
D000818:Animals; D000940:Antigenic Variation; D000943:Antigens, Differentiation; D001755:Blastocyst; D004268:DNA-Binding Proteins / Q000302:isolation & purification; D004475:Ectoderm / Q000187:drug effects; D004627:Embryonic Induction; D000939:Epitopes; D005326:Fetal Proteins / Q000302:isolation & purification; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D008648:Mesoderm / Q000502:physiology*; D009844:Oligosaccharides / Q000276:immunology / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects; D011509:Proteoglycans / Q000276:immunology / Q000378:metabolism*; D011817:Rabbits; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism; D051497:Receptor, Fibroblast Growth Factor, Type 2; D017468:Receptors, Fibroblast Growth Factor / Q000378:metabolism; D020825:T-Box Domain Proteins; D014746:Vimentin / Q000302:isolation & purification; D000098908:Brachyury Protein
D000943:Antigens, Differentiation; D004268:DNA-Binding Proteins; D000939:Epitopes; D005326:Fetal Proteins; D016222:Fibroblast Growth Factor 2; D009844:Oligosaccharides; D011509:Proteoglycans; D020794:Receptor Protein-Tyrosine Kinases; D051497:Receptor, Fibroblast Growth Factor, Type 2; D017468:Receptors, Fibroblast Growth Factor; D020825:T-Box Domain Proteins; D014746:Vimentin; D000098908:Brachyury Protein